SCHULTES BIRGIT C (EVP, Chief Scientific Officer) sold 7.9% of their position (8.51K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $78.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2026ACC: 0001193125-26-006292
Officer· EVP, Chief Scientific Officer
Since Mar 2026
-8.51K
Net shares
Net seller
$78.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.51K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.51K
Price / share
$9.21
Trade value
$78.36K
% of position
7.9%
1/5/2026
107.04K→98.53K
Total
Net shares
−8.51K
Net value
-$78.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | S · Sale | −8.51K | $9.21 | $78.36K | 7.9% | 107.04K | 98.53K |
| Total | −8.51K | -$78.36K | ||||||
Derivative Transactions0
No derivative transactions reported